Skip to content

Total debt at other companies

InfuSystem Holdings logo
InfuSystem HoldingsINFU
$24.1M-30.4%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$237.5M+32.3%
Johnson & Johnson logo
Johnson & JohnsonJNJ
Stryker logo
StrykerSYK
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$19.9M+14.6%
Gross profit$6.1M+5.8%
Operating income$3.1M-15.0%
Net income$3.9M+20.2%
EPS (diluted)$1.20+22.4%

Balance sheet

See full
Cash & equivalents$10.0M+123%
Total equity$45.2M+28.1%
Total assets$75.0M+16.7%

Cash flow

See full
Operating cash flow$1.6M+488%
CapEx$112.0K-37.8%
Free cash flow$1.5M

Valuation

See full
Market cap$195.81M+39.3%
Enterprise value$201.8M+34.4%
P/E16.3×+0.7×
P/S2.6×+0.5×

Profitability

See full
Gross margin27.8%-3.6pp
Operating margin14.5%-3.8pp
Net margin16.1%+1.5pp
FCF margin-3.8%+3.2pp

Returns & leverage

See full
Return on equity29.8%+1.5pp
Debt / equity0.4×0.0×
Current ratio3.7×+0.9×

Where this comes from

Calculated from Pro-Dex, Inc.’s reported figures.

Plus components not separately reported this period.

The official record: Pro-Dex, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pro-Dex, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pro-Dex, Inc.'s total debt?
Pro-Dex, Inc. (PDEX) reported total debt of $15.98M in Q1 2026.
How has Pro-Dex, Inc.'s total debt changed year-over-year?
Pro-Dex, Inc.'s total debt increased by 43.2% year-over-year, from $11.16M to $15.98M.
What is the long-term trend for Pro-Dex, Inc.'s total debt?
Over 4 years (2021 to 2025), Pro-Dex, Inc.'s total debt has grown at a -10.6% compound annual growth rate (CAGR), from $15.55M to $9.93M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.